Vaccines, blood, antisera, toxins and cultures in   Slovenia

Exports In 2023, Slovenia exported $939M in Vaccines, blood, antisera, toxins and cultures, making it the 23rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most exported product in Slovenia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Slovenia are: Russia ($264M), Germany ($113M), Switzerland ($79.3M), Croatia ($57M), and Bulgaria ($31.1M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Slovenia between 2022 and 2023 were Switzerland ($61.2M), Austria ($20.9M), and Croatia ($10.4M).

Imports In 2023, Slovenia imported $1.09B in Vaccines, blood, antisera, toxins and cultures, becoming the 33rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most imported product in Slovenia. Slovenia imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($475M), United States ($229M), Germany ($96.5M), Austria ($71.5M), and France ($68.8M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Slovenia between 2022 and 2023 were Austria ($24.8M), Switzerland ($15.1M), and Germany ($13.3M).